Trial Profile
Effect of tolvaptan in decompensated liver cirrhosis patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Nov 2015
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Ascites
- Focus Therapeutic Use
- 09 Nov 2015 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 20 Jan 2015 New trial record